Regulatory and intellectual property considerations for therapeutic human stem cell-based regenerative medicine product development: a US perspective

2016 ◽  
pp. 87-124
Author(s):  
Michael Mendicino ◽  
Darin Weber
Keyword(s):  
Stem Cell ◽  
Intellectual Property ◽  
Regenerative Medicine ◽  
Product Development ◽  
Human Stem Cell ◽  
Medicine Product

Considerations for Tissue-Engineered and Regenerative Medicine Product Development Prior to Clinical Trials in the United States

2010 ◽  
Vol 16 (1) ◽  
pp. 41-54 ◽  
Author(s):  
Mark H. Lee ◽  
Judith A. Arcidiacono ◽  
Anastacia M. Bilek ◽  
Jeremiah J. Wille ◽  
Caitilin A. Hamill ◽  
...  
Keyword(s):  
United States ◽  
Clinical Trials ◽  
Regenerative Medicine ◽  
Product Development ◽  
The United States ◽  
Medicine Product

scholarly journals Human stem cell research and regenerative medicine--present and future

2011 ◽  
Vol 99 (1) ◽  
pp. 155-168 ◽  
Author(s):  
V. Volarevic ◽  
B. Ljujic ◽  
P. Stojkovic ◽  
A. Lukic ◽  
N. Arsenijevic ◽  
...  
Keyword(s):  
Stem Cell ◽  
Regenerative Medicine ◽  
Stem Cell Research ◽  
Human Stem Cell

scholarly journals Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

2011 ◽  
Vol 6 (3) ◽  
pp. 367-406 ◽  
Author(s):  
Aileen J Anderson ◽  
Daniel L Haus ◽  
Mitra J Hooshmand ◽  
Harvey Perez ◽  
Christopher J Sontag ◽  
...  
Keyword(s):  
Stem Cell ◽  
Regenerative Medicine ◽  
Human Stem Cell ◽  
Cell Engraftment ◽  
The Future

scholarly journals European Scientific, Ethical, and Legal Issues on Human Stem Cell Research and Regenerative Medicine

Stem Cells ◽  
2010 ◽  
Vol 28 (6) ◽  
pp. 1005-1007 ◽  
Author(s):  
Outi Hovatta ◽  
Miodrag Stojkovic ◽  
Maria Nogueira ◽  
Isabel Varela-Nieto
Keyword(s):  
Stem Cell ◽  
Regenerative Medicine ◽  
Stem Cell Research ◽  
Legal Issues ◽  
Human Stem Cell ◽  
Ethical And Legal Issues

Patentability of inventions involving human stem cells in Europe

10.5912/jcb6 ◽  
1969 ◽  
Vol 9 (1) ◽  
Author(s):  
Philippe Bouvet
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Regenerative Medicine ◽  
European Patent ◽  
Patent Office ◽  
Human Stem Cell ◽  
Human Stem Cells ◽  
Ethical Aspects ◽  
Private Companies ◽  
European Group

In the last two years, research into stem cells has raised extraordinary therapeutic hopes – such as regenerative medicine – but also strong ethical questions. These questions have been fuelled by announcements, from private companies in particular, of the possibilities for human cloning. One of these questions relates to the patentability of inventions resulting from this area of research. In Europe this question is linked to the general debate surrounding the patentability of biological materials, such as genomic sequences. Although a large number of applications have been filed these last years, a few patents have already been issued. Some of them have been opposed at the European Patent Office. At the request of the European Commission, the European Group on Ethics (EGE) has prepared an opinion on ethical aspects of patenting inventions resulting from human stem cell research.

Sign in / Sign up

Export Citation Format

Share Document